Response to ASX Aware Letter
Open PDF
| Stock | LTR Pharma Ltd (LTP.ASX) |
|---|---|
| Release Time | 15 Jun 2026, 2:16 p.m. |
| Price Sensitive | Yes |
This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA.
The summaries are generated by large language models so please interpret with care.
LTR Pharma Ltd Responds to ASX Query Letter
Key Points
- LTR Pharma confirms the binding agreement was signed on June 8, 2026
- Company announced the agreement pre-market on June 9, 2026
- LTR Pharma relied on Listing Rule 3.1A for not disclosing earlier
- The company is in compliance with ASX Listing Rules
- Board authorized the responses to the ASX query letter
Full Summary
LTR Pharma Ltd has responded to the Australian Securities Exchange (ASX) query letter regarding the timing of their announcement about a binding agreement with Shed Holdings LLC for the distribution of ROXUS in the United States. The company confirms that the binding agreement was signed and exchanged on June 8, 2026, and was announced pre-market on June 9, 2026. LTR Pharma relied on Listing Rule 3.1A, which exempts certain information from immediate disclosure, as the agreement was still in negotiation. The company maintains that it was in compliance with ASX Listing Rules and that the responses have been authorized and approved by the Board.
Sign in to get more information about the company, including guidance changes and other insights.
Sign In